Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | 0.71% | 579.81 | 2.7% | $671.17m | |
| AMGN | Amgen, Inc. | -0.36% | 227.16 | 1.3% | $582.50m | |
| GILD | Gilead Sciences, Inc. | 0.20% | 60.79 | 1.0% | $581.98m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.71% | 211.58 | 1.9% | $512.07m | |
| ILMN | Illumina, Inc. | -0.73% | 323.55 | 3.5% | $494.75m | |
| MRNA | Moderna, Inc. | -0.44% | 70.53 | 0.0% | $473.04m | |
| ARRY | Array BioPharma Inc. | -4.42% | 42.00 | 14.2% | $403.84m | |
| IMMU | Immunomedics, Inc. | 0.00% | 87.86 | 11.0% | $392.45m | |
| NVAX | Novavax, Inc. | -0.49% | 93.13 | 96.5% | $309.58m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.62% | 121.61 | 2.0% | $277.29m | |
| BIIB | Biogen, Inc. | -0.68% | 265.00 | 1.7% | $264.24m | |
| EXAS | EXACT Sciences Corp. | 2.44% | 109.70 | 20.7% | $241.86m | |
| BNTX | BioNTech SE | 2.70% | 88.69 | 0.0% | $221.27m | |
| SRNE | Sorrento Therapeutics, Inc. | -2.42% | 8.08 | 1.4% | $162.95m | |
| SGEN | Seagen Inc. | -1.86% | 196.92 | 6.0% | $157.61m |
Company Profile
Adaptimmune Therapeutics Plc engages in the development of novel cancer immunotherapy products. Its specific peptide enhanced affinity receptor platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.